Skip to content

Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome

Controlled Study of Estrogen Effects on Cognitive and Social Function in Girls With Turner's Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00004274
Enrollment
260
Registered
1999-10-19
Start date
1990-02-28
Completion date
Unknown
Last updated
2005-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Turner's Syndrome

Keywords

Turner's syndrome, genetic diseases and dysmorphic syndromes, rare disease

Brief summary

RATIONALE: Turner's syndrome is a disease in which females are missing all or part of one X chromosome and do not produce estrogen. Giving estrogen is standard treatment for girls who have Turner's syndrome. Estrogen may be effective treatment for mental and social functioning problems experienced by girls with Turner's syndrome. PURPOSE: Clinical trial to study the effectiveness of long term estrogen therapy on mental and social functioning in girls who have Turner's syndrome.

Detailed description

PROTOCOL OUTLINE: Participants are evaluated for cognitive and social function at entry and 4 years following entry. Assessments include the Wechsler Intelligence Scale for Children-Revised, a child behavior checklist, the Children's Self-Concept Scale, and visual-spatial, visual-motor, attention, memory, language, and facial recognition tasks. Patients (and parents) undergo X-chromosome analysis; brain magnetic imaging is optional. Controls are matched using school selection and telephone interviews. A study duration of 12 years is estimated.

Interventions

DRUGEstrogen

Sponsors

Jefferson Medical College of Thomas Jefferson University
CollaboratorOTHER
National Institute of Neurological Disorders and Stroke (NINDS)
Lead SponsorNIH

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
FEMALE
Age
8 Years to 12 Years
Healthy volunteers
Yes

Inclusion criteria

PROTOCOL ENTRY CRITERIA: * Girls aged 8 and 12 years with Turner's syndrome-compatible karyotype * Age-matched girls without Turner's syndrome entered as controls * Concurrent registration on Thomas Jefferson University growth study required of subjects with Turner's syndrome

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026